WWW.JNEUROSCI.ORG
-
Life science instruments for behavioral neuroscience research
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (164)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saarelainen, T.
Right arrow Articles by Castrén, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saarelainen, T.
Right arrow Articles by Castrén, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antidepressants
Hazardous Substances DB
*FLUOXETINE
*IMIPRAMINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 2003, 23(1):349-357

Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects

Tommi Saarelainen1, *, Panu Hendolin1, *, Guilherme Lucas4, Eija Koponen1, Mikko Sairanen1, Ewen MacDonald2, Karin Agerman4, Annakaisa Haapasalo1, Hiroyuki Nawa5, Raquel Aloyz6, Patrik Ernfors4, and Eero Castrén1, 3

1 Department of Neurobiology, A. I. Virtanen Institute, Departments of 2  Pharmacology and Toxicology and 3 Psychiatry, University of Kuopio, 70211 Kuopio, Finland, 4 Department of Medical Biochemistry and Biophysics, Karolinska Institute, 17177 Stockholm, Sweden, 5 Department of Molecular Biology, Neurobiology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan, and 6 Center for Neuronal Survival, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4

Recent studies have indicated that exogenously administered neurotrophins produce antidepressant-like behavioral effects. We have here investigated the role of endogenous brain-derived neurotrophic factor (BDNF) and its receptor trkB in the mechanism of action of antidepressant drugs. We found that trkB.T1-overexpressing transgenic mice, which show reduced trkB activation in brain, as well as heterozygous BDNF null (BDNF+/-) mice, were resistant to the effects of antidepressants in the forced swim test, indicating that normal trkB signaling is required for the behavioral effects typically produced by antidepressants. In contrast, neurotrophin-3+/- mice showed a normal behavioral response to antidepressants. Furthermore, acute as well as chronic antidepressant treatment induced autophosphorylation and activation of trkB in cerebral cortex, particularly in the prefrontal and anterior cingulate cortex and hippocampus. Tyrosines in the trkB autophosphorylation site were phosphorylated in response to antidepressants, but phosphorylation of the shc binding site was not observed. Nevertheless, phosphorylation of cAMP response element-binding protein was increased by antidepressants in the prefrontal cortex concomitantly with trkB phosphorylation and this response was reduced in trkB.T1-overexpressing mice. Our data suggest that antidepressants acutely increase trkB signaling in a BDNF-dependent manner in cerebral cortex and that this signaling is required for the behavioral effects typical of antidepressant drugs. Neurotrophin signaling increased by antidepressants may induce formation and stabilization of synaptic connectivity, which gradually leads to the clinical antidepressive effects and mood recovery.

Key words: TrkB; neurotrophin receptor; antidepressant; BDNF; CREB; cerebral cortex


* T.S. and P.H. contributed equally to this work.


Copyright © 2003 Society for Neuroscience  0270-6474/03/231349-09$05.00/0


This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
G. Laje, R. H. Perlis, A. J. Rush, and F. J. McMahon
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Psychiatr Serv, November 1, 2009; 60(11): 1446 - 1457.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
K. Narushima, S. Paradiso, D. J. Moser, R. Jorge, and R. G. Robinson
Effect of Antidepressant Therapy on Executive Function after Stroke
Focus, July 1, 2009; 7(3): 424 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. Bozdagi, E. Rich, S. Tronel, M. Sadahiro, K. Patterson, M. L. Shapiro, C. M. Alberini, G. W. Huntley, and S. R. J. Salton
The Neurotrophin-Inducible Gene Vgf Regulates Hippocampal Function and Behavior through a Brain-Derived Neurotrophic Factor-Dependent Mechanism
J. Neurosci., September 24, 2008; 28(39): 9857 - 9869.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. E. Malberg and L. M. Monteggia
VGF, a New Player in Antidepressant Action?
Sci. Signal., May 6, 2008; 1(18): pe19 - pe19.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Thakker-Varia, J. J. Krol, J. Nettleton, P. M. Bilimoria, D. A. Bangasser, T. J. Shors, I. B. Black, and J. Alder
The Neuropeptide VGF Produces Antidepressant-Like Behavioral Effects and Enhances Proliferation in the Hippocampus
J. Neurosci., November 7, 2007; 27(45): 12156 - 12167.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
K. Narushima, S. Paradiso, D. J. Moser, R. Jorge, and R. G. Robinson
Effect of antidepressant therapy on executive function after stroke
The British Journal of Psychiatry, March 1, 2007; 190(3): 260 - 265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yagasaki, T. Numakawa, E. Kumamaru, T. Hayashi, T.-P. Su, and H. Kunugi
Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release
J. Biol. Chem., May 5, 2006; 281(18): 12941 - 12949.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Hajszan and N. J. MacLusky
Neurologic links between epilepsy and depression in women: Is hippocampal neuroplasticity the key?
Neurology, March 28, 2006; 66(66_suppl_3): S13 - S22.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
D. Tardito, J. Perez, E. Tiraboschi, L. Musazzi, G. Racagni, and M. Popoli
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
Pharmacol. Rev., March 1, 2006; 58(1): 115 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Sairanen, G. Lucas, P. Ernfors, M. Castren, and E. Castren
Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus
J. Neurosci., February 2, 2005; 25(5): 1089 - 1094.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist, December 1, 2004; 10(6): 575 - 593.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. DeLong
Autism and Familial Major Mood Disorder: Are They Related?
J Neuropsychiatry Clin Neurosci, May 1, 2004; 16(2): 199 - 213.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. S. Newton, E. F. Collier, J. Hunsberger, D. Adams, R. Terwilliger, E. Selvanayagam, and R. S. Duman
Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors
J. Neurosci., November 26, 2003; 23(34): 10841 - 10851.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-